Novavax Begins Midstage Study of COVID-19 Vaccine in South Africa Novavax Begins Midstage Study of COVID-19 Vaccine in South Africa

US drug developer Novavax said it started a midstage study of its experimental COVID-19 vaccine in South Africa, as the country experiences a surge in coronavirus cases.Reuters Health Information
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Family Medicine/Primary Care News Source Type: news